Haemonetics Corp. (HAE) Tops Q2 EPS by 9c
Tweet Send to a Friend
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.66, $0.09 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
